Abstract
Glucocorticoid (GC) is used to treat a wide variety of inflammatory and allergic diseases, but often brings about various adverse effects, including osteoporosis and subsequent bone fracture. GC-induced osteoporosis, thereby, should be treated and also be prevented. Accumulated evidence indicates that treatment with a bisphosphonate is recommended for prevention as well as treatment of GC-induced osteoporosis in all men and postmenopausal women, in whom will receive or have received long-term GC treatment. Further studies would provide additional options for treatment or prevention of GC-induced osteoporosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
